Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plcverified

HEMO.L

Price:

$1.4597

Market Cap:

$18.06M

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal H...[Read more]

Industry

Biotechnology

IPO Date

2015-11-09

Stock Exchange

LSE

Ticker

HEMO.L

The Current Ratio as of September 2024 (TTM) for Hemogenyx Pharmaceuticals Plc (HEMO.L) is 3.33

According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Current Ratio is 3.33. This represents a change of -10.09% compared to the average of 3.70 of the last 4 quarters.

Hemogenyx Pharmaceuticals Plc (HEMO.L) Historical Current Ratio (quarterly & annually)

How has HEMO.L Current Ratio performed in the past?

The mean historical Current Ratio of Hemogenyx Pharmaceuticals Plc over the last ten years is 6.24. The current 3.33 Current Ratio has changed 5.24% with respect to the historical average. Over the past ten years (40 quarters), HEMO.L's Current Ratio was at its highest in in the September 2021 quarter at 20.23. The Current Ratio was at its lowest in in the January 2015 quarter at 0.

Quarterly (TTM)
Annual

Average

6.24

Median

4.47

Minimum

0

Maximum

20.23

Hemogenyx Pharmaceuticals Plc (HEMO.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Current Ratio = 20.23

Minimum Annual Increase = -82.86%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20233.33-4.03%
20223.47-82.86%
202120.231.78%
20201.08-64.71%
20193.05-72.38%
201811.0649.76%
20177.381.27%
20167.2933.31%
20155.47Infinity%

Hemogenyx Pharmaceuticals Plc (HEMO.L) Average Current Ratio

How has HEMO.L Current Ratio performed in the past?

The current Current Ratio of Hemogenyx Pharmaceuticals Plc (HEMO.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.01

5-year avg

6.23

10-year avg

6.24

Hemogenyx Pharmaceuticals Plc (HEMO.L) Current Ratio vs. Peers

How is HEMO.L’s Current Ratio compared to its peers?

Hemogenyx Pharmaceuticals Plc’s Current Ratio is less than Omega Diagnostics Group PLC (4.29), greater than genedrive plc (1.63), greater than Avacta Group Plc (0.62), greater than Novacyt S.A. (2.10), less than Synairgen plc (9.01),

CompanyCurrent RatioMarket cap
4.29$4.94M
1.63$11.35M
0.62$231.14M
2.10$50.57M
9.01$8.31M

Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Hemogenyx Pharmaceuticals Plc's Current Ratio?

How is the Current Ratio calculated for Hemogenyx Pharmaceuticals Plc (HEMO.L)?

What is the highest Current Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?

What is the 3-year average Current Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?

What is the 5-year average Current Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L)?

How does the current Current Ratio for Hemogenyx Pharmaceuticals Plc (HEMO.L) compare to its historical average?